NAS:WMGI (Netherlands) Also Trade In: Delisted Germany

Wright Medical Group NV $ 29.98 0 (0%)

Avg Vol (1m):
Market Cap $:
3.90 Bil
Enterprise Value $:
4.98 Bil
P/E (TTM):
Warning! GuruFocus has detected 4 Severe warning signs with WMGI. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

WMGI News and Headlines - Wright Medical Group NV

GuruFocus Articles Total 17
  • 1

GMO releases portfolio, buys include Humana and Lyft

Grantham Mayo Van Otterloo, the firm co-founded by Jeremy Grantham (Trades, Portfolio), disclosed this week that its top five buys for fourth-quarter 2019 were Humana Inc. (HUM), Lyft Inc. (LYFT), The Stars Group Inc. (TSG), Wright Medical Group NV (WMGI) and Tiffany & Co. (TIF).

According to its website, GMO applies a long-term, valuation-based investment philosophy to unlock shareholder value for its clients. The firm also mentions that most of the “interesting” investing opportunities occur at market extremes and that pursuing contrarian strategies can result in good value creation.


As of

422 Views    James Li    2020-02-13 21:21
Guru stock highlight

Wright Medical Group, NV (WMGI - $30.48 - NASDAQ) (WMGI), is a medical device manufacturer specializing in lower extremity (foot, ankle), upper extremity (shoulder, elbow, wrist) and biologic products to mechanically repair tissue-to-tissue and tissue-to-bone injuries. Despite an execution mis-step that led the stock down 31% in the third quarter, the company’s growth by acquisition strategy and unique positioning in the orthopedics space attracted the attention of Stryker (SYK) who offered to acquire Wright at a 50% premium.

From Keeley Asset Management's Keeley Small-Mid Cap Value Fund fourth-quarter 2019 shareholder commentary.

22 Views    Sydnee Gatewood    2020-01-23 17:58
Discussion of markets and holdings

To Our Shareholders:

For the quarter ended December 31, 2019, the KEELEY Small-Mid Cap Value Fund’s net asset value (“NAV”) per Class A share increased 9.64% versus a gain of 7.07% for the Russell 2500 Value Index. During the full-year 2019, the Fund gained 31.65% versus 23.57% for the Russell 2500 Value Index.


The old adage, “Don’t fight the Fed” remains true. With the Fed on hold given the dovish bias for 2020, plus the outlook for renewed growth in trade/capital spending as the uncertainty is lifted with Phase I of the China/US trade agreement, the market posted another

52 Views    Sydnee Gatewood    2020-01-23 17:56
Guru stock highlight

Wright Medical Group NV (WMGI) is a medical device manufacturer specializing in lower extremity (foot, ankle), upper extremity (shoulder, elbow, wrist) and biologic products to mechanically repair tissue-to-tissue and tissue-to-bone injuries. The stock was down 31% as the company missed second quarter expectation and lowered guidance for the year. The miss resulted from the loss of sales people in Lower Extremities to competition and the loss of the distributor network for its recent acquired Cartiva product. The company is aggressively rebuilding its salesforce and will now handle all Cartiva product sales internally. Management feels it can rectify this within

61 Views    Sydnee Gatewood    2019-10-15 21:12
Discussion of markets and holdings

To Our Shareholders:

For the quarter ended September 30, 2019, the KEELEY Small-Mid Cap Value Fund’s net asset value (“NAV”) per Class A share increased 0.90% versus a gain of 0.13% for the Russell 2500 Value Index. Year to date, the Fund is up 20.08% versus 15.41% for the Russell 2500 Value Index.


Similar to last quarter, what appeared to be a flattish market environment was anything but flat. The strong run-up in the market in June, with the Fed posturing it would cut rates for the first time since 2007, continued into July with the S&P 500 Index

34 Views    Sydnee Gatewood    2019-10-15 21:09
Guru drastically boosts position in medical device company

Billionaire investor Steven Cohen (Trades, Portfolio), who leads Point72 Asset Management, disclosed on May 10 that he expanded his stake in Intersect ENT Inc. (XENT) by 221.55%.

The guru’s Connecticut-based hedge fund seeks to generate superior risk-adjusted returns using long, short, macro and systematic strategies.

According to GuruFocus Real-Time Picks, a Premium feature, Cohen invested in 1.16 million shares of the California-based medical devices manufacturer on May 9. He now holds 1.68 million shares of the company, which represent approximately 0.23% of the equity portfolio. During the quarter, the stock traded for an average price of

369 Views    Sydnee Gatewood    2019-05-14 16:18
Guru stock highlight

Wright Medical Group, NV (NASDAQ:WMGI) is a global orthopedic medical device company focused on upper/lower extremities and biologics. The company underperformed as it suffered disruption from a sizable sales force expansion that ultimately resulted in the company reducing earnings guidance. While it is taking much longer for the new sales representatives to reach full productivity, the 50% increase in the size of the salesforce will ultimately be beneficial for the company as it results in accelerating sales and earnings growth.

From the Keeley All Cap Value Fund fourth quarter 2017 shareholder letter.

33 Views    Holly LaFon    2018-02-07 23:22
Discussion of portfolio and holdings

To Our Shareholders:

For the quarter ended December 31, 2017, the KEELEY All Cap Value Fund’s net asset value (“NAV”) per Class A share rose 6.03% versus a gain of 5.08% for the Russell 3000 Value Index. For the year, the Fund gained 12.29% compared with a 13.19% gain for the Index.


The markets ended the year on a strong note, with the major US equity indices at or near all-time highs. The holiday cheer was not confined to the US as stock markets in the UK, France, Germany, Japan, India, and Brazil all closed the year at or

200 Views    Holly LaFon    2018-02-07 23:15
Guru stock highlight

Wright Medical Group (NASDAQ:WMGI) is a global medical device company focused on extremities and biologics. The company had exceeded analysts’ estimates for the past four quarters and EBITDA margins have increased from -5.5% in 4Q15 to 11.7% in 4Q16, on its way towards their 20% margin target by 2019. Unfortunately, the company missed first quarter 2017 earnings as a planned salesforce expansion did not lead to increased sales as quickly as hoped. Underlying metrics remain strong and the company should recover as the year proceeds. In addition, a recent Financial Times article reported on speculation that a larger orthopedic

45 Views    Holly LaFon    2017-08-14 18:32
Overview of markets and stocks

To Our Shareholders:

For the quarter ended June 30, 2017, the Keeley All Cap Value Fund’s net asset value (“NAV”) per Class A share declined by 2.21% versus a gain of 1.29% for the Russell 3000 Value.


Despite various fits and starts, the domestic economy grew steadily in the second quarter of 2017. Although job growth reports during the quarter were muted, with March and May nonfarm payrolls falling short of consensus estimates, the April report presented a rosier picture. The general choppiness in this data seemed to create confusion for investors about the overall direction of the economy.

108 Views    Holly LaFon    2017-08-14 16:51
Fund discusses the political environment and performance

A Word On The Markets

Global equity markets delivered solid gains in the first quarter of 2017 despite a pullback by U.S. stocks late in the period amid dimming prospects for President Donald Trump’s pro”‘business agenda.

U.S. stocks advanced for much of the period, extending the rally that began with President Trump’s election in November. Responding to continued economic growth, the U.S. Federal Reserve (the Fed) raised its benchmark interest rate in March and indicated that further rate hikes would be coming in 2017.Taking the Fed action as a vote of confidence in the U.S. economy, stocks rose following the

86 Views    Holly LaFon    2017-05-02 16:37
Guru stock highlight

Wright Medical Group (NASDAQ:WMGI) is a global medical device company focused on extremities and biologics. The company completed a merger of equals with Tornier NV in late 2015 becoming the worldwide leader in providing surgical solutions for upper extremities (shoulder, elbow, wrist and hands), lower extremities (foot and ankle) and biologics (bone graft stimulators) - three of the fastest growing segments in orthopedics. Both companies had been investing heavily for growth resulting in low, short-term profitability, but under new CEO Robert Palmisano, the combined company has substantial scale opportunities and would be a beneficiary of the aging, but much

39 Views    Holly LaFon    2017-04-27 19:25
Letter to shareholders

To Our Shareholders:

For the quarter ended March 31, 2017, the Keeley Small Cap Value Fund’s net asset value (“NAV”) per Class A share appreciated 0.93% versus a decline of 0.13% for the Russell 2000 Value.


Donald Trump’s unexpected Presidential election victory ignited a rally in equities that continued through the first quarter leading the bull market into its eighth year. While investors spent much of the beginning of the year enthused about pro-business policies out of Washington given expectations of tax reform, infrastructure spending and an easing of regulatory burdens, the rally lost some steam toward the end

116 Views    Holly LaFon    2017-04-27 16:59
Guru stock highlight

One of the Fund’s main drivers this quarter was Wright Medical Group (NASDAQ:WMGI), which gained nearly 40% and contributed 141 basis points in performance. The company provides surgical solutions for the foot and ankle market and its products include joint implants for hip and knee replacements. The company reported a strong second quarter and raised guidance, proving the benefit of the Tornier acquisition.

From Keeley All Cap Value Fund third-quarter 2016 commentary.

631 Views    Holly LaFon    2016-10-21 19:55
Discussion of investing environment and holdings

U.S. equity markets whipsawed in the third quarter, with the emergence of unexpected events as a common thread. The quarter began with equities in full, bull-market mode owing to a rebound from post-Brexit declines – declines that notably occurred because so few investors actually expected the Brexit vote to pass. Then, in July and August, generally positive earnings and strong, risk-on appetites produced nice gains.

In September, however, the appetite for risk lessened amid volatility from steeper valuations, weaker economic data and the inherent uncertainty in a presidential race that has been the very definition of the unexpected, with no

539 Views    Holly LaFon    2016-10-21 16:49
Investor reports latest quarterly portfolio

Samuel Isaly (Trades, Portfolio), manager of the Eaton Vance Worldwide Health Care Fund (ETHSX), invested in three health care companies and eliminated his position in three others during the second quarter of 2016. An active health care investor, Isaly seeks long-term capital growth in health care companies that have potential for high growth and increased market share. The portfolio manager generally has 80% of his assets in health sciences industries, including biotechnology, pharmaceuticals and medical equipment.

The ETHSX portfolio manager made three new buys during the second quarter: Biomarin Pharmaceutical Inc. (BMRN), UnitedHealth Group Inc. (UNH) and

1121 Views    James Li    2016-07-29 22:23
Guru stock highlight

Health Care proved to be challenging this quarter and our leading detractors all came from this sector. Despite a positive quarter and the completion of a recent European based acquisition, Wright Medical Group (NASDAQ:WMGI) stock was pressured on fears of potential litigation involving metal to metal hip implants, which could exceed the company’s liability insurance. Other orthopedic companies have suffered from similar legal disputes involving alleged, early device failure in recent years. A judgement was recently handed down on its first case with 80% less in damages awarded than had been initially estimated. Regardless of what appears to be

745 Views    Holly LaFon    2016-04-26 22:09

Headlines Total 73
  • 1

2020-11-13 $ 29.98 (%)
2020-07-20 $ 29.83 (-0.37%)
2020-07-16 $ 30 (0.27%)
2020-06-06 $ 29.79 (0.3%)
2020-05-22 $ 29.45 (0.2%)
2020-05-15 $ 29.7 (0.03%)
2020-05-08 $ 29.87 (0.4%)
2020-05-04 $ 29.77 (0.81%)
2020-04-28 $ 29.27 (0.17%)
2020-04-21 $ 29.16 (1.11%)
2020-04-09 $ 27.98 (0.61%)
2020-04-08 $ 27.81 (2.32%)
2020-03-25 $ 28.3 (1.25%)
2020-03-24 $ 27.95 (4.68%)
2020-03-17 $ 26.81 (1.17%)
2020-02-05 $ 30.31 (0.03%)
2020-01-31 $ 30.14 (0.03%)
2020-01-23 $ 30.26 (0.2%)
2019-11-28 $ 29.97 (%)
2019-11-22 $ 29.52 (0.1%)
2019-11-20 $ 29.51 (-0.27%)
2019-11-15 $ 29.39 (%)
2019-11-04 $ 29.04 (31.94%)
2019-10-15 $ 20.33 (0.15%)
2019-10-09 $ 19.72 (-1.99%)
2019-09-12 $ 21.53 (2.97%)
2019-08-01 $ 28.36 (-1.73%)
2019-07-17 $ 26.33 (-1.31%)
2019-05-07 $ 29.38 (-2.52%)
2019-04-17 $ 29.01 (-3.04%)
2019-04-09 $ 30.25 (-0.46%)
2019-04-02 $ 30.93 (-1.65%)
2019-03-13 $ 31.43 (0.13%)
2019-03-12 $ 31.58 (1.54%)
2019-02-05 $ 29.84 (0.51%)
2019-01-31 $ 29.84 (-0.43%)
2019-01-23 $ 28.6 (-0.9%)
2019-01-07 $ 27.86 (0.29%)
2018-12-11 $ 27.13 (2.42%)
2018-11-19 $ 28.52 (-3.45%)
2018-10-25 $ 27.53 (3.26%)
2018-10-10 $ 26.79 (-1.47%)
2018-10-03 $ 28.21 (-0.46%)
2018-08-28 $ 26.79 (-4.22%)
2018-08-27 $ 26.79 (-4.22%)
2018-07-11 $ 25.67 (0.23%)
2018-06-21 $ 27.11 (-0.48%)
2018-06-13 $ 25.78 (4.46%)
2018-05-29 $ 24.97 (0.6%)
2018-05-17 $ 24.38 (0.79%)
2018-04-11 $ 20.19 (4.34%)
2018-02-07 $ 20.88 (-2.75%)
2017-08-14 $ 28.55 (2.7%)
2017-04-27 $ 30.45 (-0.07%)
2016-10-21 $ 24.2 (-0.74%)
2016-04-26 $ 19.04 (1.44%)
Total 73
  • 1